https://pimreceptor.com/index.....php/assessment-invol
An extended follow up of HRQoL 36 and 60 months after randomisation is provided. A multicentre randomised controlled trial was carried out at seven vascular clinics in Sweden between 2010 and 2020. A hundred patients randomised to either major stenting and best medical treatment (BMT; n= 48) or BMT alone (n= 52) had been used for 60 months. HRQoL, assessed by the brief Form 36 Health Survey (SF-36) and EuroQoL 5 measurements (EQ5D) 36 and 60 months after randomisation, had be
Like
Comment
Share
